Director/PDMR Shareholding

RNS Number : 8074M

Hikma Pharmaceuticals Plc

13 May 2020

 

Hikma Pharmaceuticals PLC

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Said Darwazah

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Said Darwazah
2	Reason for the notification
a)	Position/status	Executive Chairman
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083
b)	Nature of the transaction	Liquidation of HMS Holdings SAL resulting in the disposal of 1,350,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC.  HMS Holdings SAL is defined as a Person Closely Associated with the Executive Chairman, who is a shareholder.
c)	Price(s) and volume(s)	Price(s): £24.50p Volume(s): 1,350,000
d)	Aggregated information	Aggregated volume: 1,350,000 Price: £24.50p
e)	Date of the transaction	13 May 2020
f)	Place of the transaction	London

 Mazen Darwazah

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Mazen Darwazah
2	Reason for the notification
a)	Position/status	Executive Vice Chairman
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083
b)	Nature of the transaction	Liquidation of HMS Holdings SAL resulting in the disposal of 1,350,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC.   HMS Holdings SAL is defined as a Person Closely Associated with the Executive Vice Chairman, who is a shareholder.
c)	Price(s) and volume(s)	Price(s): £24.50p Volume(s): 1,350,000
d)	Aggregated information	Aggregated volume: 1,350,000 Price: £24.50p
e)	Date of the transaction	13 May 2020
f)	Place of the transaction	London

Peter Speirs
Company Secretary, responsible for releasing this announcement
[phone]

 

END

 

 

DSHBDGDULDBDGGX